Impact of Ultra High-risk Genetics on Real-world Outcomes of Transplant-eligible Multiple Myeloma Patients

Impact of Ultra High-risk Genetics on Real-world Outcomes of Transplant-eligible Multiple Myeloma Patients

Refined prediction of early relapse following standard-of-care (SoC) autologous stem cell transplant (ASCT) in newly diagnosed multiple myeloma (NDMM) could inform real-world risk-stratified post-ASCT strategies. We investigated the impact of double hit genetics (≥2 adverse markers: t(4;14), t(14;16...

Full description

Bibliographic Details
Main Authors: Aikaterini Panopoulou, Sandra Easdale, Mark Ethell, Emma Nicholson, Mike Potter, Asterios Giotas, Helena Woods, Tracy Thornton, Charlotte Pawlyn, Kevin D. Boyd, Martin F. Kaiser
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000831

Internet

http://journals.lww.com/10.1097/HS9.0000000000000831

Similar Items